RedHill Biopharma (RDHL) Shares Outstanding (2011 - 2025)

RedHill Biopharma (RDHL) has reported Shares Outstanding (Entity) for 14 consecutive years, with $14.8 million the latest figure, recorded in Q4 2025.

• On a quarterly basis, Shares Outstanding (Entity) changed N/A year-over-year to $14.8 million in Q4 2025; TTM through Dec 2025 was $14.8 million, a N/A change from a year earlier, with the FY2025 full-year figure at $14.8 million, changed N/A from the prior year.
• Shares Outstanding (Entity) was $14.8 million for Q4 2025 at RedHill Biopharma, down from $259.1 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $259.1 million in Q4 2023 and troughed at $14.8 million in Q4 2025.
• A 4-year average of $97.1 million and a median of $57.3 million in 2021 frame the typical range for Shares Outstanding (Entity).
• Across the five-year window, Shares Outstanding (Entity) climbed 17.55% in 2022 and soared 318.41% in 2023, its largest moves.
• Over 4 years, Shares Outstanding (Entity) stood at $52.7 million in 2021, then gained by 17.55% to $61.9 million in 2022, then soared by 318.41% to $259.1 million in 2023, then sank by 94.3% to $14.8 million in 2025.
• The last three Shares Outstanding (Entity) figures came in at $14.8 million (Q4 2025), $259.1 million (Q4 2023), and $61.9 million (Q4 2022), per Business Quant data.